Inflammatory

CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study

Authors: T J Barber, A Imaz, M Boffito, J Niubó, A Pozniak, R Fortuny, J Alonso, N Davies, S Mandalia, D Podzamczer, B Gazzard

Journal: Journal of Neurovirology

Year Published: 2018

CINAMMON is a phase IV, open-label, single-arm, pilot study assessing maraviroc (MVC) in the central nervous system (CNS) when added to darunavir/ritonavir monotherapy (DRV/r) in virologically suppressed HIV-infected subjects. CCR5 tropic participants on DRV/r were recruited. […]

Back to Publications